Sign in
4

Changes in Ownership

Atara Biotherapeutics, Inc. Filed Acc 0001209191-20-031005

Chief Financial Officer sold 1,428 shares at $11.22 ($16,022)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Koppikar Utpal Chief Financial Officer 2020-05-18 Sale −1,428 $11.22 $16,022 137,375 D
Open-market sales · 1,428 sh · avg $11.22 · $16,022
Loading xslF345X03/doc4.xml…